Granules India Limited

granulesindia.com

Granules India Ltd. is a fully integrated pharmaceutical manufacturer. The Company manufactures Active Pharmaceutical Ingredients (APIs), Pharmaceutical Formulation Intermediates (PFIs) and Finished Dosages (FDs) which are distributed in over 55 countries.

C-Suite On Deck

Responsive image

Feature market insights and perspectives from top C-Level executives, elite technology influencers and thought leaders from your company here. This signature initiative has garnered immense support...

Contact Us

Events

Related News

Business Insights

ERT EXPANDS CLINICAL IMAGING REPORTING CAPABILITIES IN ITS BUSINESS INTELLIGENCE SUITE

ERT | April 16, 2021

news image

ERT, the worldwide pioneer in clinical endpoint data collection, today declared that its demonstrated Business Intelligence suite has extended to incorporate detailing for clinical preliminary imaging, making study data all the more effectively available and noteworthy. The new imaging capabilities give an elevated degree of data that empowers study pioneers to guarantee consummation, and successfully oversee locales, expenses, and profitability. "Imaging studies are complex,...

Read More

Business Insights

RESILIENCE ESTABLISHES MULTI-PRODUCT DEVELOPMENT AND MANUFACTURING COLLABORATION WITH TAKEDA’S PLASMA-DERIVED THERAPIES BUSINESS UNIT

Resilience | February 16, 2022

news image

National Resilience, Inc. a technology-focused manufacturing company dedicated to broadening access to complex medicines, announced a manufacturing services agreement with Takeda’s Plasma-Derived Therapies Business Unit. As part of the agreement, Resilience will focus on supporting the development and manufacture of multiple products in Takeda’s plasma-derived medicines portfolio out of its facility in Mississauga, Ontario. “I...

Read More

PHARMA TECH

OM1 LAUNCHES ASTHMA AND CHRONIC RHINOSINUSITIS DATASETS TO EXPAND REAL-WORLD EVIDENCE IN RESPIRATORY AND ENT

Business Wire | October 05, 2023

news image

OM1, a leading real-world data, AI, and technology company with a focus on chronic diseases, announced the launch of two new clinical datasets, Chronic Rhinosinusitis (CRS) and Asthma. Both datasets are derived from longitudinal follow-up of patients seen by specialists and focus on patient characteristics, symptoms, treatments, clinical outcomes and healthcare resource utilization. Rapidly growi...

Read More

Pharma Tech

KIOMED PHARMA AND HANSOH PHARMA ANNOUNCE LICENSE AGREEMENT FOR KIOMEDINEVSONE IN CHINA’S MAINLAND, MACAU AND TAIWAN

KiOmed Pharma and Hansoh Pharma | September 27, 2022

news image

KiOmed Pharma, a Belgian biotechnology company with a focus on the development, manufacture and distribution of safe and effective medical devices based on a medical-grade highly pure natural chitosan-derivative, and Hansoh Pharmaceutical Group Company Limited a leading biopharmaceutical company in Asia, today announced a license agreement for the development and commercialization of KiOmedinevsOne, a carboxymethyl chitosan injection that has been launched in Europe for the treatment of knee ost...

Read More
news image

Business Insights

ERT EXPANDS CLINICAL IMAGING REPORTING CAPABILITIES IN ITS BUSINESS INTELLIGENCE SUITE

ERT | April 16, 2021

ERT, the worldwide pioneer in clinical endpoint data collection, today declared that its demonstrated Business Intelligence suite has extended to incorporate detailing for clinical preliminary imaging, making study data all the more effectively available and noteworthy. The new imaging capabilities give an elevated degree of data that empowers study pioneers to guarantee consummation, and successfully oversee locales, expenses, and profitability. "Imaging studies are complex,...

Read More
news image

Business Insights

RESILIENCE ESTABLISHES MULTI-PRODUCT DEVELOPMENT AND MANUFACTURING COLLABORATION WITH TAKEDA’S PLASMA-DERIVED THERAPIES BUSINESS UNIT

Resilience | February 16, 2022

National Resilience, Inc. a technology-focused manufacturing company dedicated to broadening access to complex medicines, announced a manufacturing services agreement with Takeda’s Plasma-Derived Therapies Business Unit. As part of the agreement, Resilience will focus on supporting the development and manufacture of multiple products in Takeda’s plasma-derived medicines portfolio out of its facility in Mississauga, Ontario. “I...

Read More
news image

PHARMA TECH

OM1 LAUNCHES ASTHMA AND CHRONIC RHINOSINUSITIS DATASETS TO EXPAND REAL-WORLD EVIDENCE IN RESPIRATORY AND ENT

Business Wire | October 05, 2023

OM1, a leading real-world data, AI, and technology company with a focus on chronic diseases, announced the launch of two new clinical datasets, Chronic Rhinosinusitis (CRS) and Asthma. Both datasets are derived from longitudinal follow-up of patients seen by specialists and focus on patient characteristics, symptoms, treatments, clinical outcomes and healthcare resource utilization. Rapidly growi...

Read More
news image

Pharma Tech

KIOMED PHARMA AND HANSOH PHARMA ANNOUNCE LICENSE AGREEMENT FOR KIOMEDINEVSONE IN CHINA’S MAINLAND, MACAU AND TAIWAN

KiOmed Pharma and Hansoh Pharma | September 27, 2022

KiOmed Pharma, a Belgian biotechnology company with a focus on the development, manufacture and distribution of safe and effective medical devices based on a medical-grade highly pure natural chitosan-derivative, and Hansoh Pharmaceutical Group Company Limited a leading biopharmaceutical company in Asia, today announced a license agreement for the development and commercialization of KiOmedinevsOne, a carboxymethyl chitosan injection that has been launched in Europe for the treatment of knee ost...

Read More

Resources

Events

C-Suite On Deck

Responsive image

Feature market insights and perspectives from top C-Level executives, elite technology influencers and thought leaders from your company here. This signature initiative has garnered immense support...

Contact Us